CBE ID
0546
Endorsed
New or Maintenance
Is Under Review
No
Measure Description
The percentage of patients who were dispensed a medication for diabetes and hypertension that are receiving an angiotensin-converting -enzyme-inhibitor (ACEI) or angiotensin receptor blocker (ARB) or direct renin inhibitor (DRI) renin-angiotensin-antagonist medication.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisData dictionary not attachedNoNumerator
The number of patients who receive an ACEI or ARB or DRI or ACEI/ARB/DRI Combination during the measurement year.
DenominatorPatients who were dispensed at least one prescription for an oral hypoglycemic agent, insulin, incretion mimetics, and at least one prescription for an antihypertensive agent during the measurement year.
All information required to stratify the measure resultsOffAll information required to stratify the measure resultsOff
- Measure StructureClinical Condition Topic AreaTarget PopulationNational Quality Strategy PrioritiesEffective Communication and Care Coordination
- Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Endocrine Endorsement Maintenance ProjectInitial EndorsementEndorsement StatusLast UpdatedRemoval Date
- Do you have a secondary measure developer point of contact?OffThe measure developer is NOT the same as measure stewardOnStewardSteward Organization EmailSteward Phone NumberSteward Organization URLSteward Organization Copyright
NA
- Detailed Measure SpecificationsNoLogic ModelOffImpact and GapNoFeasibility assessment methodology and resultsNoAddress health equityNoMeasure’s use or intended useNo508 ComplianceOff